GPMDB00263OtherBassani-Sternberg M, et al.InstrumentNot AvailableNot availableHomo_sapiens_viruses, HumanNot availablemmann@biochem.mpg.dehttp://gpmdb.thegpm.org/~/dblist_gpmnum/gpmnum=GPM11210034390http://gpmdb.thegpm.org/~/dblist_gpmnum/gpmnum=GPM11210034391http://gpmdb.thegpm.org/~/dblist_gpmnum/gpmnum=GPM11210034389http://gpmdb.thegpm.org/~/dblist_gpmnum/gpmnum=GPM11210034396http://gpmdb.thegpm.org/~/dblist_gpmnum/gpmnum=GPM11210034397http://gpmdb.thegpm.org/~/dblist_gpmnum/gpmnum=GPM11210034387http://gpmdb.thegpm.org/~/dblist_gpmnum/gpmnum=GPM11210034388http://gpmdb.thegpm.org/~/dblist_gpmnum/gpmnum=GPM11210034392http://gpmdb.thegpm.org/~/dblist_gpmnum/gpmnum=GPM11210034393http://gpmdb.thegpm.org/~/dblist_gpmnum/gpmnum=GPM11210034394http://gpmdb.thegpm.org/~/dblist_gpmnum/gpmnum=GPM11210034395Max-Planck Institute of Biochemistry; Novo Nordisk Foundation Center for Protein ResearchNot availableGPMDBMass Spectrum Analysis, Spectroscopy, Mass Spectrum, strong, polypeptide, Antigen Processings, Antigen Presentations, antigen presentation, resilient, Analyses, tough, Mass, Antigen Processing, Spectrometry, Analysis, proteins, Spectrum Analyses, antigen processing., Mass Spectrum Analyses, Spectrum Analysis, Mass SpectroscopyMass Spectrum Analysis, Mass Spectrum, data, Malignant Neoplasm, Analyses, Identification, ligand, Spectrometry, Cell Lines, malignant neoplasia, Identifications (Psychology), cell line cell, present in organism, cell_line, Cancers, Spectrum Analyses, cell_type, Spectrum Analysis, malignant tumor, Cell, cell line, Spectroscopy, Polypeptides, HCT116 cell, Workflows, ligand., Mass, Line, HCT-116 cell, Analysis, Work Flow, Mass Spectrum Analyses, Work Flows, malignant tumour, Mass Spectroscopy, Cancer, Lines260http://gpmdb.thegpm.org/~/dblist_gpmnum/gpmnum=GPM112100343923dbgap_ncbi~0patentfamilies~0rfam~0merops~0complex-portal~0uniprot~0wormbaseparasite~0embl-covid19~0reactome~0emdb~0wgs_masters~0ebiweb_resources~0opentargets_genetics~0biomodels_all~0ipd-mhc~0ebiweb_teams~0taxonomy~0genome_assembly~0sc-experiments~0ebiweb_people~0enzymeportal_enzymes~0ipd-nhkir~0cellosaurus~0pdbe~0chebi~0patentproteins~0interpro7~0uniref~0chembl~0pdbekb~0gpcrdb~0hgnc~0sc-genes~0intact~0rhea~0ebiweb_training~0alphafold~0imgt-hla~0patentnucleotides~0ensemblroot~0eva_studies~0non-coding~0europepmc~0identifiers_registry~0pdbechem~0hpa-covid19~0eva-variants-covid19~0biosamples~0gwas_catalog~0biotools~0tls_masters~0mesh~0coding~0sra~0opentargets~0efo~0embl-pathogen~0project~0pride~1human_diseases~0geo_datasets~0embl~0treefam~0uniparc~0ols~0dgva~0intenz~0go~0tsa_masters~0biosamples-covid19~0ebiweb_corporate~0omim~0lrg~0earlycause-molecular-sequences~0ipd-kir~0empiar~0rnacentral~0orcid_data_claims~0gpmdb~1lineage-covid19~0metagenomics~0pfam~0pride archive~1varsite~00Resource Reanalysis0.00.00.0080197409006785930.01.0falseMass spectrometry of HLA-I peptidomes reveals strong effects of protein abundance and turnover on antigen presentationData from ProteomeXchange, PXD ID: PXD000394. Cell type: HCT116, file: 20120617_EXQ0_MiBa_SA_HCT116_1_mHLA_2hr.mzml. Published as part of . From the Abstract: {{i}} ... Here we present a high-throughput mass spectrometry based workflow that allows stringent and accurate identification of thousands of such peptides and direct determination of binding motifs. Applying the workflow to seven cancer cell lines and primary cells, yielded more than 22,000 unique HLA peptides across different allelic binding specificities ... {{/i}}2015-01-12GPM11210034392PXD000394PXD000394